Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9344 |
High Similarity |
NPD3027 |
Phase 3 |
0.887 |
High Similarity |
NPD228 |
Approved |
0.8672 |
High Similarity |
NPD1613 |
Approved |
0.8672 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8571 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8504 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8254 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.8254 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.8175 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.814 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7969 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7953 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7951 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.792 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7836 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7833 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7832 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7812 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7803 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7786 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7724 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7704 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7692 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7687 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7687 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.768 |
Intermediate Similarity |
NPD7157 |
Approved |
0.766 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.763 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7627 |
Intermediate Similarity |
NPD846 |
Approved |
0.7627 |
Intermediate Similarity |
NPD940 |
Approved |
0.7623 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7623 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7619 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7603 |
Intermediate Similarity |
NPD290 |
Approved |
0.7594 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7584 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7568 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7565 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7542 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7538 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7538 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7536 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7534 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7518 |
Intermediate Similarity |
NPD3060 |
Approved |
0.75 |
Intermediate Similarity |
NPD37 |
Approved |
0.75 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7483 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7479 |
Intermediate Similarity |
NPD291 |
Approved |
0.745 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7431 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7431 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7429 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7426 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7426 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7422 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7413 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7394 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7376 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7365 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7365 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7355 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7351 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7351 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7351 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7351 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7339 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7329 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7299 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7261 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7254 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7252 |
Intermediate Similarity |
NPD9381 |
Approved |
0.7252 |
Intermediate Similarity |
NPD9384 |
Approved |
0.7246 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7215 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7206 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7203 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7194 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.719 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7177 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7171 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD7472 |
Approved |
0.717 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7165 |
Intermediate Similarity |
NPD821 |
Approved |
0.7164 |
Intermediate Similarity |
NPD9622 |
Approved |
0.7164 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7153 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD9280 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7114 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7114 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7113 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7105 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7097 |
Intermediate Similarity |
NPD968 |
Approved |
0.709 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7086 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7075 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7071 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7067 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7047 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7043 |
Intermediate Similarity |
NPD9094 |
Approved |
0.7042 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7042 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7042 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7034 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7034 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7031 |
Intermediate Similarity |
NPD9379 |
Approved |
0.7031 |
Intermediate Similarity |
NPD9377 |
Approved |
0.7029 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7021 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7021 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7019 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7007 |
Intermediate Similarity |
NPD9621 |
Approved |
0.7007 |
Intermediate Similarity |
NPD9620 |
Approved |
0.7007 |
Intermediate Similarity |
NPD9619 |
Approved |
0.7007 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.6993 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6992 |
Remote Similarity |
NPD1778 |
Approved |
0.6992 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6992 |
Remote Similarity |
NPD4626 |
Approved |
0.6992 |
Remote Similarity |
NPD5846 |
Approved |
0.698 |
Remote Similarity |
NPD1350 |
Approved |
0.698 |
Remote Similarity |
NPD1349 |
Approved |
0.698 |
Remote Similarity |
NPD1351 |
Approved |
0.6978 |
Remote Similarity |
NPD3180 |
Approved |
0.6978 |
Remote Similarity |
NPD3179 |
Approved |
0.6975 |
Remote Similarity |
NPD1432 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6975 |
Remote Similarity |
NPD2934 |
Approved |
0.6975 |
Remote Similarity |
NPD2933 |
Approved |
0.6972 |
Remote Similarity |
NPD6653 |
Approved |
0.6972 |
Remote Similarity |
NPD1607 |
Approved |
0.6962 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD5297 |
Approved |
0.6959 |
Remote Similarity |
NPD1774 |
Approved |
0.695 |
Remote Similarity |
NPD943 |
Approved |
0.6944 |
Remote Similarity |
NPD6099 |
Approved |
0.6944 |
Remote Similarity |
NPD6100 |
Approved |
0.6944 |
Remote Similarity |
NPD2161 |
Phase 2 |
0.694 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6939 |
Remote Similarity |
NPD5241 |
Discontinued |
0.6939 |
Remote Similarity |
NPD2677 |
Approved |
0.6933 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6933 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6929 |
Remote Similarity |
NPD5109 |
Approved |
0.6929 |
Remote Similarity |
NPD5110 |
Phase 2 |
0.6929 |
Remote Similarity |
NPD556 |
Approved |
0.6929 |
Remote Similarity |
NPD598 |
Approved |
0.6929 |
Remote Similarity |
NPD601 |
Approved |
0.6929 |
Remote Similarity |
NPD5111 |
Phase 2 |
0.6929 |
Remote Similarity |
NPD597 |
Approved |
0.6917 |
Remote Similarity |
NPD844 |
Approved |
0.6917 |
Remote Similarity |
NPD2859 |
Approved |
0.6917 |
Remote Similarity |
NPD2860 |
Approved |
0.6914 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6913 |
Remote Similarity |
NPD3157 |
Approved |
0.6913 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6913 |
Remote Similarity |
NPD1424 |
Approved |
0.6913 |
Remote Similarity |
NPD3158 |
Phase 1 |
0.6906 |
Remote Similarity |
NPD600 |
Approved |
0.6906 |
Remote Similarity |
NPD596 |
Approved |
0.6901 |
Remote Similarity |
NPD3657 |
Discovery |
0.6901 |
Remote Similarity |
NPD5735 |
Approved |
0.6901 |
Remote Similarity |
NPD447 |
Suspended |
0.6897 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6894 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6894 |
Remote Similarity |
NPD1408 |
Clinical (unspecified phase) |
0.6885 |
Remote Similarity |
NPD3020 |
Approved |
0.6883 |
Remote Similarity |
NPD5772 |
Approved |
0.6883 |
Remote Similarity |
NPD5773 |
Approved |
0.6879 |
Remote Similarity |
NPD1136 |
Approved |
0.6879 |
Remote Similarity |
NPD840 |
Approved |
0.6879 |
Remote Similarity |
NPD839 |
Approved |
0.6879 |
Remote Similarity |
NPD1132 |
Approved |
0.6879 |
Remote Similarity |
NPD1130 |
Approved |
0.6875 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6875 |
Remote Similarity |
NPD5588 |
Approved |
0.6875
|
Remote Similarity |
NPD7473 |
Discontinued |